Effects of switching from liraglutide to semaglutide or dulaglutide in patients with type 2 diabetes: A randomized controlled trial

ConclusionsSwitching from once-daily liraglutide to once-weekly semaglutide 0.5  mg significantly improved glycemic control and body weight compared with switching to once-weekly dulaglutide 0.75 mg.

Source: Journal of Diabetes Investigation - March 5, 2023 Category: Endocrinology Authors: Takahiro Iijima, Shibuya Makoto, Yuzuru Ito, Yasuo Terauchi Tags: Clinical Trial Source Type: research